Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease. (Q46786200)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 November 2005
edit
Language Label Description Also known as
English
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.
scientific article published on 2 November 2005

    Statements

    Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit